Ignite Creation Date:
2024-05-06 @ 3:34 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04670575
Status:
COMPLETED
Last Update Posted:
2024-05-20
First Post:
2020-12-13
Brief Title:
Vivity Outcomes in Patients With Early Stage Glaucoma
Sponsor:
Vance Thompson Vision
Organization:
Vance Thompson Vision
Study Overview
Official Title:
Vivity Outcomes in Patients With Early Stage Glaucoma
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
Not yet recruiting
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VIVA
Brief Summary:
The goal of the study is to determine the visual outcomes in patients with mild pre-perimetric glaucoma who undergo cataract surgery with implantation of the Alcon Vivity Extended Range Intraocular Lens IOL
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None